The role of the microcirculation in acute kidney injury

Current Opinion in Critical Care

Volumn 15, Issue 6, 2009, Pages 503-508

  Le Dorze, Matthieu ^a,b   Legrand, Matthieu ^a,b   Payen, Didier ^b   Ince, Can ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Acute kidney injury; Acute renal failure; Endothelium; Microcirculation; Nitric oxide; Oxygenation; Reactive oxygen species

Indexed keywords

NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ENDOTHELIUM INJURY; HUMAN; HYPOXEMIA; KIDNEY CIRCULATION; KIDNEY INJURY; MICROCIRCULATION; NONHUMAN; OXYGEN TISSUE LEVEL; REVIEW;

ANOXIA; ENDOTHELIUM; HOMEOSTASIS; HUMANS; KIDNEY FAILURE, ACUTE; MICROCIRCULATION; NITRIC OXIDE; OXYGEN CONSUMPTION; REACTIVE OXYGEN SPECIES;

EID: 74949108404     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e328332f6cf     Document Type: Review

References (62)

1. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure: definition, outcome measures, animal models, fluids therapy and information technology needs: the second international consensus conference of acute dialysis quality initiative group. Crit Care 2004; 8:R204-212.
2. Osterman M, Chang RWS. Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 2007; 35:1837-1843.
3. Hoste EA, Schurgers M. Epidemiology of acute kidney injury: how big is the problem? Crit Care Med 2008; 36:S146-S151.
4. Bagshaw SM. Short and long-term survival after acute kidney injury. Nephrol Dial Transplant 2008; 23:2126-2128.
5. Rosenberger C, Rosen S, Heyman SN. Renal parenchymal oxygenation and hypoxia adaptation in acute kidney injury. Clin Exp Pharmacol Physiol 2006; 33:980-988.
6. Evans RG, Gardiner BS, Smith DW, et al. Intrarenal oxygenation: unique challenge and the biophysical basis of homeostasis. Am J Physiol Renal Physiol 2008; 295:F1259-F1270.
7. Johannes T, Mik EG, Ince C. Dual-wavelength phosphorimetry for determination of cortical and subcortical microvascular oxygenation in rat kidney. J Appl Physiol 2006; 100:1301-1310.
8. Leong CL, Anderson PW, O'Connor PM, et al. Evidence that renal arteriovenous shunting contributes to dynamic regulation of renal oxygenation. Am J Physiol Renal Physiol 2007; 292:1726-1733.
9. Brezis M, Agmon Y, Epstein FH. Determinants of intrarenal oxygenation. 1. Effects of diuretics. Am J Physiol 1994; 267:F1059-F1062. (Pubitemid 124005388)
10. Yamamoto T, Tada T, Brodsky SV, et al. Intravital videomicroscopy of peritubular capillaries in renal ischemia. Am J Physiol Renal Physiol 2002; 282:F1150-F1155.
11. Wu L, Tiwari MM, Messer KF, et al. Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mouse. Am J Physiol Renal Physiol 2007; 292:F261-268.
12. Schmitz V, Schaser KD, Olschewski P, et al. In vivo visualization of early microcirculatory changes following ischemia/reperfusion injury in human kidney transplantation. Eur Surg Res 2008; 40:19-25.
13. Sutton TA, Mang HE, Campos SB, et al. Injury of the renal microvascular endothelium alters barrier function after ischemia. Am J Physiol Renal Physiol 2003; 285:F191-198.
14. Sutton TA. Alteration of microvascular permeability in acute kidney injury. Microvasc Res 2009; 77:4-7.
15. Johannes T, Mik EG, Ince C. Nonressuscitated end endotoxemia induces microcirculatory hypoxic areas in the renal cortex in the rats. Shock 2009; 31:97-103.
16. Brodsky SV, Yamamoto T, Tada T, et al. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted epithelial cells. Am J Physiol Renal Physiol 2002; 282:F1140-1149.
17. Bonventre JV, Weinberg JM. Recent advances in the physiopathology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14:2199-2210.
18. Jerkic M, Miloradovic Z, Jovovic D, et al. Relative roles of endothelin-1 and angiotensin II in experimental postischemic acute renal failure. Nephrol Dial Transplant 2004; 19:83-94.
19. Legrand M, Mik EG, Johannes T, et al. Hypoxia and dysoxia after reperfusion of ischemic kidney. Mol Med 2008; 14:502-516.
20. Miloradovic Z, Jerkic M, Jovovic D, et al. Bosentan and losartan ameliorate acute renal failure associated with mild but not strong NO blockage. Nephrol Dial Transplant 2007; 22:2276-2484.
21. Gulmen S, Kiris I, Narin C, et al. Tezosentan reduces the renal injury induced by abdominal aortic ischemia-reperfusion in rats. J Surg Res 2009; 22:4804-4809.
22. Johannes T, Mik EG, Ince C, et al. Effects of 1400W and/or nitroglycerin on renal oxygenation and kidney function during endotoxemia in anesthetized rats. Clin Exp Pharmacol Physiol 2009; Apr 27. [Epub ahead of print]
23. Johannes T, Ince C, Mik EG, et al. Iloprost preserves renal oxygenation and restores kidney function in endotoxemia-related acute renal failure in the rat. Crit Care Med 2009; 37:1423-1432.
24. Johannes T, Mik EG, Ince C, et al. Low dose dexamethasone-supplemented fluid reverses endotoxin induced acute renal failure and prevents cortical microvascular hypoxia. Shock 2009; 31:521-528.
25. Melican K, Boekel J, Mansson LE, et al. Bacterial infection-mediated mucosal signalling induces local renal ischemia as a defence against sepsis. Cell Microbiol 2008; 10:1987-1998.
26. Cao CC, Ding XQ, Zhu CF, et al. In vivo transfection NF-kappaB decoy oligodeoxynucleotides attenuates renal ischemia/reperfusion injury in rats. Kidney Int 2004; 65:834-845.
27. Jang HR, Rabb H. The innate immune response in ischemic acute kidney injury. Clin Immunol 2009; 130:41-50.
28. Jayle C, Milinkevitch S, Favreau F, et al. Protective role of selectin ligand inhibition in a large animal model of kidney ischemia-reperfusion injury. Kidney Int 2006; 69:1749-1755.
29. Kato N, Yuzawa Y, Kosugi T, et al. The E-selectin ligand basigin/CD147 is responsible for neutrophil recruitment in renal ischemia-reperfusion. J Am Soc Nephrol 2009; 10:1046.
30. Kelly KJ, WilliamsWWJr, Colvin RB, et al. Intercellular adhesion molecule-1- deficient mice are protected against ischemic renal injury. J Clin Invest 1996; 97:1056-1063.
31. Oh DJ, Dursun B, He Z. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice. Am J Physiol Renal Physiol 2008; 294:F264-271.
32. De Greef K, Ysebaert S, Dauwe S, et al. Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int 2001; 60:1415-1427.
33. Ysebaert DK, De Greef KE, Vercauteren SR, et al. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 2000; 15:1562-1574.
34. Ysebaert DK, De Greef KE, De Beuf A, et al. T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 2004; 66:491-496.
35. Thurman JM. Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol 2006; 123:7-13.
36. Celie JW, Rutjes NW, Keuning ED, et al. Subendothelial heparin sulfate proteoglycans become major L-selectin and monocyte chemoattractant protein 1 ligands upon renal ischemia/reperfusion. Am J Pathol 2007; 170:1865-1878.
37. Guan Z, Gobe G, Willgoss D, et al. Renal endothelial dysfunction and impaired autoregulation after ischemia-reperfusion injury result from excess nitric oxide. Am J Physiol Ren Physiol 2006; 291:F619-628.
38. Legrand M, Payen D, Ince C, et al. L-NIL prevents microvascular hypoxia and increase of renal oxygen consumption after ischemia-reperfusion in rats. Am J Physiol Renal Physiol 2009; 296:1109-1117.
39. Agmon Y, Peleg H, Greenfeld Z, et al. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast nephrotoxicity. J Clin Invest 1994; 94:1069-1075.
40. Chatterjee PK, Patel NSA, Kvale EO, et al. Inhibition of inductible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int 2002; 61:862-871.
41. Aurojo M, Welch WJ. Oxidative stress and nitric oxide in kidney function. Curr Opin Nephrol Hypertens 2006; 15:72-77.
42. Myers SI, Wang L, Liu F, et al. Oxygen-radical regulation of renal blood flow following suprarenal aortic clamping. J Vasc Surg 2006; 43:577-586.
43. Chatterjee PK, Cuzzocrea S, Brown PAJ, et al. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int 2000; 58:658-673. (Pubitemid 30620015)
44. Rubio-Gayosso I, Platts SH, Dulling BR. Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2006; 290:H2247-2256.
45. Hughes AK, Stricklett PK, Padilla E, et al. Effect of reactive oxygen species on endothelin-1 production by human mesangial cells. Kidney Int 1996; 49:181-189.
46. Yamada K, Miwa T, Liu J, et al. Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J Immunol 2004; 172:3869-3875.
47. Bellomo R. The epidemiology of acute renal failure: 1975 versus 2005. Cur Opin Crit Care 2006; 12:557-560.
48. Trof RJ, Di Maggio F, Leemreis J, et al. Biomarkers of acute renal failure. Shock 2006; 26:245-253.
49. De Backer D, Hollenberg S, Ince C, et al. How to evaluate the microcirculation: report of a round table conference. Crit Care 2007; 11:R101.
50. Johannes T, Mik EG, Ince C, et al. Acute decrease in renal microvascular PO2 during acute normovolemic hemodilution. Am J Physiol renal Physiol 2007; 292:796-803; Crit Care 2007.
51. Tsai AG, Cabrales P, Intaglietta M, et al. Microvascular perfusion upon exchange transfusion with stored red blood cells in normovolemic anemic conditions. Transfusion 2004; 44:1626-1634.
52. Deruddre S, Cheisson G, Mazoit JX, et al. Renal arterial resistance in septic shock: effects of increasing mean arterial pressure with norepinephrine on the renal resistive index assessed with Doppler ultrasonography. Intensive Care Med 2007; 33:1557-1562.
53. Macias WL, Yan SB, Williams MD, et al. New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated). Crit Care 2005; 9:S38-45.
54. PROWESS study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. New Engl J Med 2001; 344:699-709.
55. Gupta A, Guerlitz B, Richardson MA, et al. Distinct functions of activated protein C differentially attenuate acute kidney injury. J Am Soc Nephrol 2009; 20:267-277.
56. Song YR, Lee T, You SJ, et al. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am J Nephrol 2009; 30:253-260.
57. Liakopoulos OJ, Choi YH, Haldenwang PN, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. Eur Heart J 2008; 29:1548-1559.
58. Ventura CG, Coimbra TM, de Campos SB, et al. Mycophenolate mofetil attenuates renal ischemia/reperfusion injury. J Am Soc Nephrol 2002; 13:2524-2533.
59. Ysebaert DKY, De Greef KE, Vercauteren SR, et al. Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/ reperfusion renal injury. Kidney Int 2003; 64:864-873.
60. Van Der Voort PH, Boerma EC, Koopmans, et al. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial. Crit Care Med 2009; 37:533-538.
61. Amabile N, Guerin AP, Leroyer A, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005; 16:3381-3388.
62. Basile DP, Donohoe D, Roethe K, et al. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001; 281:887-899.